TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
ADRX

ADARx Pharmaceuticals, Inc.

Healthcare · Biotechnology

14.00$ -1.4% vs. previous close Closing price · As of: Nov 16, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement ADRX
Line item Q1 25 Q2 25 Q1 26 Q2 26
– 100.0% 100.0% 100.0%
– 8,208.2% 1,101.9% 3,316.1%
– 2,046.6% 262.4% 790.8%
– 10,254.8% 1,364.3% 4,106.8%
– -10,154.8% -1,264.3% -4,006.8%
– -8,698.6% -1,059.2% -3,452.9%
– -8,698.6% -1,059.2% -3,452.9%
– -9,853.8% -1,230.7% -3,908.3%

Data as of: November 16, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?